International review of blood donation screening for anti‐HBc and occult hepatitis B virus infection
Transfusion · 2024-11 · 64 (11) · 2144-2156
DOI: 10.1111/trf.18018 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Transfusion, online erschienen am 02.10.2024. Verfasst von Michael X Fu und 46 weiteren Autor:innen. Beteiligte Einrichtung: Nuffield Department of Medicine, University of Oxford, Oxford, UK. Hauptthemen laut MEDLINE: Blood Donors, Hepatitis B, Hepatitis B Antibodies, Hepatitis B virus. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute for Health and Care Research.
Abstract (Originalsprache)
Background
Hepatitis B core antibody (anti‐HBc) screening has been implemented in many blood establishments to help prevent transmission of hepatitis B virus (HBV), including from donors with occult HBV infection (OBI). We review HBV screening algorithms across blood establishments globally and their potential effectiveness in reducing transmission risk. Materials and Methods A questionnaire on HBV screening and follow‐up strategies was distributed to members of the International Society of Blood Transfusion working party on transfusion‐transmitted infectious diseases. Screening data from 2022 were assimilated and analyzed.
Results
A total of 30 unique responses were received from 25 countries. Sixteen respondents screened all donations for anti‐HBc, with 14 also screening all donations for HBV DNA. Anti‐HBc prevalence was 0.42% in all blood donors and 1.19% in new donors in low‐endemic countries; however, only 44% of respondents performed additional anti‐HBc testing to exclude false reactivity. 0.68% of anti‐HBc positive, HBsAg‐negative donors had detectable HBV DNA. Ten respondents did universal HBV DNA screening without anti‐HBc, whereas four respondents did not screen for either. Deferral strategies for anti‐HBc positive donors were highly variable. One transfusion‐transmission from an anti‐HBc negative donor was reported.
Discussion
Anti‐HBc screening identifies donors with OBI but also results in the unnecessary deferral of a significant number of donors with resolved HBV infection and donors with false‐reactive anti‐HBc results. Whilst confirmation of anti‐HBc results could be improved to reduce donor deferral, transmission risks associated with anti‐HBc negative OBI donors must be considered. In high‐endemic areas, highly sensitive HBV DNA testing is required to identify infectious donors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nuffield Department of Medicine, University of Oxford, Oxford, UK.
- School of Health, University of the Sunshine Coast, Petrie, Queensland, Australia.
- Research and Development, Australian Red Cross Lifeblood, Brisbane, Queensland, Australia.
- Institut Mondor de Recherche Biomédicale, INSERM U955, Team Virus-Hepatology-Cancer, Henri Mondor Hospital, University Paris-Est, Créteil, France.
- American Red Cross, Baltimore, Maryland, USA.
- Australian Red Cross Lifeblood, Melbourne, Australia.
ORCID-Profile: Michael X Fu, Helen M Faddy, Daniel Candotti, Jamel Groves, Paula Saa, Claire Styles, Jose Perez Carrillo, Axel Seltsam, Sheila F O'Brien, Steven J Drews, Xuelian Deng, Thijs van de Laar, Syria Laperche, Wai-Chiu Tsoi, David Juhl, Masahiro Satake, Antoine Lewin, Michel-Andres Garcia-Otalora, Marion Vermeulen, Monique Andersson, Peter Simmonds
Förderung
- National Institute for Health and Care Research
Zitieren
APA
Fu, M. X., Faddy, H. M., Candotti, D., Groves, J., Saa, P., Styles, C., Adesina, O., Carrillo, J. P., Seltsam, A., Weber-Schehl, M., O'Brien, S. F., Drews, S. J., Aidoo, N. B., Pajares, Á. L., Perez, L. N., Deng, X., van de Laar, T., Laperche, S., Lehtisalo, R., …, & Virology subgroup of the ISBT WP‐TTID (2024). International review of blood donation screening for anti‐HBc and occult hepatitis B virus infection. Transfusion, 64(11), 2144-2156. https://doi.org/10.1111/trf.18018
Vancouver
Fu MX, Faddy HM, Candotti D, Groves J, Saa P, Styles C, et al. International review of blood donation screening for anti‐HBc and occult hepatitis B virus infection. Transfusion. 2024;64(11):2144-2156. doi:10.1111/trf.18018
BibTeX
@article{Fu2024,
author = {Fu, Michael X and Faddy, Helen M and Candotti, Daniel and Groves, Jamel and Saa, Paula and Styles, Claire and Adesina, Opeyemi and Carrillo, Jose Perez and Seltsam, Axel and Weber-Schehl, Marijke and O'Brien, Sheila F and Drews, Steven J and Aidoo, Nana Benyin and Pajares, Ángel Luis and Perez, Laura Navarro and Deng, Xuelian and van de Laar, Thijs and Laperche, Syria and Lehtisalo, Riikka and Yilmaz, Soner and Tsoi, Wai-Chiu and Juhl, David and Niederhauser, Christoph and Chenarsabz, Nahid and O'Flaherty, Niamh and Goto, Naoko and Satake, Masahiro and Renaud, Christian and Lewin, Antoine and Cloutier, Marc and Sawadogo, Salam and Reynolds, Claire and Zhiburt, Eugene and Muylaert, An and Van Gaever, Véronique and Garcia-Otalora, Michel-Andres and Jarvis, Lisa and Vermeulen, Marion and Busch, Michael and Blackmore, Stuart and Jones, Ann and Brailsford, Su and Irving, William L and Andersson, Monique and Simmonds, Peter and Harvala, Heli and Virology subgroup of the ISBT WP‐TTID, Virology subgroup of the ISBT WP‐TTID},
title = {International review of blood donation screening for anti‐HBc and occult hepatitis B virus infection},
journal = {Transfusion},
year = {2024},
volume = {64},
number = {11},
pages = {2144--2156},
doi = {10.1111/trf.18018}
}
EUVIMED